Akers Biosciences Inc (AKER):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Akers Biosciences Inc (AKER) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6533
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:89
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRON, PIFA PLUSS PF4, tri-cholesterol, PIFA chlamydia, PIFA dengue fever, PIFA malaria, PIFA syphilis, PIFA heparin, and breath ketone. ABI provides testing platform technologies, which include micro particle catalyzed biosensor, particle immune-filtration assay, rapid enzymatic assay, rapid blood cell separation, and synthetic macrocycle complex. The company serves medical clinicians, individuals, corporations, and law enforcement agencies, health professionals. ABI is headquartered in West Deptford, New Jersey, the US.

Akers Biosciences Inc (AKER) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Akers Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Akers Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Akers Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Akers Biosciences Inc, Medical Equipment, Deal Details 11
Partnerships 11
Akers Biosciences Enters into Distribution Agreement with Diagnostica Stago 11
Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 12
Akers Biosciences Enters into Distribution Agreement with Aero-Med 13
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 14
Akers Biosciences Enters into Distribution Agreement with Medline Industries 15
Akers Biosciences Enters into Distribution Agreement with Typenex 16
Equity Offering 17
Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 17
Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 18
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 19
Akers Biosciences Raises USD0.3 Million in Private Placement of Shares up on Exercise of Warrants 20
Akers Biosciences Raises USD2.1 Million in Private Placement of Shares upon Exercise of Warrants 21
Akers Biosciences Raises USD6.9 Million in Public Offering of Units 22
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 24
Akers Biosciences Plans to Raise up to USD3.6 Million in Public Offering of Shares 25
Akers Biosciences to Raise USD2 Million in Private Placement of Shares 26
Akers Biosciences Prices Public Offering of Shares and Warrants for USD2 Million 27
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 28
Akers Biosciences Inc – Key Competitors 29
Akers Biosciences Inc – Key Employees 30
Akers Biosciences Inc – Locations And Subsidiaries 31
Head Office 31
Other Locations & Subsidiaries 31
Joint Venture 31
Recent Developments 32
Financial Announcements 32
Aug 14, 2018: Akers Biosciences announces Q2 and H1 2018 earnings 32
Jul 13, 2018: Akers Biosciences Announces Q1 2018 Earnings 40
Apr 03, 2018: Akers Biosciences Reports Earnings for Fiscal Year 2017 47
Nov 15, 2017: Akers Biosciences Announces Q3 2017 Earnings 52
Aug 15, 2017: Akers Biosciences: Financial Results for the Six Months Ended June 30, 2017 61
Aug 15, 2017: Akers Biosciences Announces Q2 2017 Earnings 63
Aug 03, 2017: Akers Biosciences Announces Second Quarter Trading Update 67
May 16, 2017: Akers Biosciences Announces Q1 2017 Earnings 68
Apr 11, 2017: Akers Bioscience: Financial Results for the Year Ended December 31, 2016 70
Apr 11, 2017: Akers Biosciences Reports Earnings for Fiscal Year 2016 72
Mar 30, 2017: Akers Biosciences Reports Preliminary Unaudited Earnings Highlights for Fiscal Year 2016 76
Corporate Communications 78
Sep 13, 2018: Akers Biosciences: Directorate change – form 8-K filing 78
May 29, 2018: Akers Biosciences Announces Board Change 79
Apr 26, 2018: Akers Biosciences: Directorate Change 80
Sep 07, 2017: Akers Biosciences Hires Medical Device Specialist to Lead US Sales and Distribution 81
Aug 08, 2017: Akers Biosciences Announces Board Changes 82
Legal and Regulatory 84
Jun 29, 2018: Akers Biosciences Requests Temporary Suspension of Trading on London Stock Exchange 84
May 25, 2018: Akers Biosciences Receives Notice of Delinquent Form 10-Q Filing from Nasdaq 85
Product News 86
Apr 24, 2017: Akers Biosciences Updates on Akers Wellness Tests 86
Other Significant Developments 87
Oct 08, 2018: Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update 87
Appendix 89
Methodology 89
About GlobalData 89
Contact Us 89
Disclaimer 89

List of Tables
Akers Biosciences Inc, Medical Equipment, Key Facts, 2017 2
Akers Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Akers Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Akers Biosciences Inc, Deals By Market, 2012 to YTD 2018 9
Akers Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Akers Biosciences Enters into Distribution Agreement with Diagnostica Stago 11
Akers Biosciences Enters into Distribution Agreement with First Check Diagnostics 12
Akers Biosciences Enters into Distribution Agreement with Aero-Med 13
Akers Biosciences Forms Joint Venture with Hainan Savy Investment Management 14
Akers Biosciences Enters into Distribution Agreement with Medline Industries 15
Akers Biosciences Enters into Distribution Agreement with Typenex 16
Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 17
Akers Biosciences Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 18
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 19
Akers Biosciences Raises USD0.3 Million in Private Placement of Shares up on Exercise of Warrants 20
Akers Biosciences Raises USD2.1 Million in Private Placement of Shares upon Exercise of Warrants 21
Akers Biosciences Raises USD6.9 Million in Public Offering of Units 22
Akers Biosciences Raises Funds in Private Placement of Shares upon Exercise of Warrants 24
Akers Biosciences Plans to Raise up to USD3.6 Million in Public Offering of Shares 25
Akers Biosciences to Raise USD2 Million in Private Placement of Shares 26
Akers Biosciences Prices Public Offering of Shares and Warrants for USD2 Million 27
Akers Biosciences Completes Public Offering Of Shares For US$15 Million 28
Akers Biosciences Inc, Key Competitors 29
Akers Biosciences Inc, Key Employees 30
Akers Biosciences Inc, Subsidiaries 31
Akers Biosciences Inc, Joint Venture 31

List of Figures
Akers Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Akers Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Akers Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Akers Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Akers Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Akers Biosciences Inc (AKER):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • TIM SpA (TIT):企業の財務・戦略的SWOT分析
    TIM SpA (TIT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Pharmagest Interactive SA (PHA):企業の財務・戦略的SWOT分析
    Summary Pharmagest Interactive SA (Pharmagest Interactive) is a technology company that develops and markets professional IT solutions for pharmacies and pharmaceutical industries. The company operates through four divisions such as pharmaceutical, fintech, e-health, and health and medico-social div …
  • Emera Inc.:企業の戦略・SWOT・財務情報
    Emera Inc. - Strategy, SWOT and Corporate Finance Report Summary Emera Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • United Internet AG:企業のM&A・事業提携・投資動向
    United Internet AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's United Internet AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Bridgelux Inc:電力:M&Aディール及び事業提携情報
    Summary Bridgelux Inc (Bridgelux) is a power products manufacturer that designs and markets light-emitting diode technologies and solutions. The company offers products such as Decor series, H series, OLM series, V series, Vero series, SMD products, LED chips and BXRA3 series bulbs. It also provides …
  • OBB-Infrastruktur AG:企業の戦略的SWOT分析
    OBB-Infrastruktur AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • The Federal Reserve System:企業の戦略的SWOT分析
    The Federal Reserve System - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Vale Canada Ltd:企業の戦略・SWOT・財務分析
    Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report Summary Vale Canada Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Mayne Pharma Group Ltd (MYX):企業の財務・戦略的SWOT分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma) formerly HalcyGen Pharmaceuticals Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company offers products such as erymax capsules, kapanol capsules, doryx capsules, magnoplasm, astrix c …
  • Shanghai Shyndec Pharmaceutical Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Shyndec Pharmaceutical Co Ltd (Shanghai Shyndec) a subsidiary of China National Pharmaceutical Group Corp, is a pharmaceutical company which focuses on the production and sale of active pharmaceutical ingredients (API’s), oral preparations and finished drugs. Its product portfolio i …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Sumitomo Chemical Co., Ltd.:企業の戦略・SWOT・財務分析
    Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Comet Ridge Ltd (COI):石油・ガス:M&Aディール及び事業提携情報
    Summary Comet Ridge Ltd (CRL) is an oil and gas exploration and production company that acquires, explores and develops oil and gas properties. The company holds interests in Mahalo project located in the Denison trough area of Queensland's Bowen Basin near Rolleston. It also holds interest in PEL 6 …
  • Response Biomedical Corp:医療機器:M&Aディール及び事業提携情報
    Summary Response Biomedical Corp (Response Biomedical) focuses on the research, development, manufacture and marketing of diagnostic technologies for the point-of-care (POC), central-lab testing and on-site environmental testing markets. It offers Cardiovascular tests such as Troponin-I, Myoglobin, …
  • Vindhya Telelinks Ltd:企業の戦略・SWOT・財務分析
    Vindhya Telelinks Ltd - Strategy, SWOT and Corporate Finance Report Summary Vindhya Telelinks Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Adams Resources & Energy, Inc.:企業の戦略・SWOT・財務分析
    Adams Resources & Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Adams Resources & Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Qualicaps Inc:企業の戦略的SWOT分析
    Qualicaps Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Virco Mfg Corp (VIRC):企業の財務・戦略的SWOT分析
    Summary Virco Mfg Corp (Virco) operates as a manufacturer and supplier of furniture and equipment for educational and commercial applications. The company offers chairs, desks, tables, filing cabinets, mobile cabinets, media towers, chair trucks, table trucks, bookcases, and accessories. It provides …
  • David Lloyd Leisure Ltd:企業の戦略・SWOT・財務情報
    David Lloyd Leisure Ltd - Strategy, SWOT and Corporate Finance Report Summary David Lloyd Leisure Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • New Britain Palm Oil Limited:企業の戦略・SWOT・財務情報
    New Britain Palm Oil Limited - Strategy, SWOT and Corporate Finance Report Summary New Britain Palm Oil Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆